Novo Shares Plummet 21%, Wiping Out $100 Billion
Novo's U.S.-listed shares see a dramatic 21% drop, erasing over $100 billion in market value. Discover the impact on the pharmaceutical giant.
Novo's U.S.-listed shares plunged 21%, erasing over $100 billion in market value.